Data refreshed:

Tender cb-912-87371785

Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.

In plain English

What it is
Request For Proposal (RFP) for Pharmacological testing of novel stimulants, and synthetic cannabinoids.
Who's buying
Department of Health (HC)
What they want
Amended Request For Proposal (RFP) for Pharmacological testing of stimulants, and synthetic cannabinoids. Novel psychoactive substances (NPS) in the illegal drug supply pose risks to Canadians. However, little is known about their pharmacological activity. More potent drugs increase the risk of overdose risks. Evidence on the pharmacological activity of these substances is essential to support scientific regulatory activities and risk assessments. The illegal drug supply is continuously evolving, with new substances continually being detected. There is a need for further information on their h…
Deadline
Nov 9, 2026, 17:00 UTC
How to bid
Submit through CanadaBuys before the deadline, following the instructions in the official notice. Method: Competitive - Open bidding.
Contact
Shallee Doll · [email protected] · 000000000

Notice details

Status
Open
Solicitation number
1000273405-1A
Notice type
Request for Proposal
Published
Oct 27, 2026
Category (UNSPSC)
Drugs and pharmaceutical products
Regions of delivery
Not specified

Similar open tenders

Past awards in this category

  • SO - Naloxone Nasal Spray - Emergent BioSolutions Canada Inc

    CW2464479

    Vendor
    Emergent BioSolutions Canada Inc.
    Value
    $3,000,000
    Awarded
    Aug 20, 2026
  • 21120-268734 Cystic Fibrosis Medications NISO

    CW2448497

    Vendor
    McKesson Canada Corporation
    Value
    $4,000,000
    Awarded
    Apr 10, 2026
  • K4E21-260484 REMOTE MEDICAL HEALTH CARE SUPPORT WITH MEDICAL SUPPLY KITS

    CW2441337

    Vendor
    PRAXES Medical Group
    Value
    $79,147
    Awarded
    Apr 9, 2026
  • Hepatitis B Vaccines Merck

    CW2447092

    Vendor
    Merck Canada Inc.
    Value
    $3,855,797
    Awarded
    Apr 1, 2026
  • Hepatitis B Vaccines GSK

    CW2447088

    Vendor
    GlaxoSmithKline Inc.
    Value
    $9,462,827
    Awarded
    Apr 1, 2026
  • Contract (GSK) - Supply Pertussis-containing vaccines

    CW2445891

    Vendor
    GlaxoSmithKline Inc.
    Value
    $29,400,277
    Awarded
    Mar 30, 2026

Get alerts for tenders like this

One free daily digest. No account needed. Unsubscribe any time.